AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

10.1016/j.jhep.2009.10.008

Saved in:
Bibliographic Details
Main Authors: Huynh, H, Ngo, V.C., Soo, K.C., Koong, H.N., Poon, D., Choo, S.P., Toh, H.C., Thng, C.H., Chow, P., Ong, H.S., Chung, A., Goh, B.C., Smith, P.D.
Other Authors: PHARMACOLOGY
Format: Article
Published: 2011
Subjects:
Angiogenesis
Apoptosis
Combined therapy
Growth inhibition
HCC xenografts
Online Access:http://scholarbank.nus.edu.sg/handle/10635/27256
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/27256

Similar Items